Approval · Notice of Compliance 7966 · 2006
FLUOTIC: Notice of Compliance 7966
Issued May 16, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7966
- Date
- May 16, 2006
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Medical treatment of otospongiosis
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLUOTIC | 02099225 | Cancelled Post Market |
Medicinal ingredients
- SODIUM FLUORIDE 20 MG per TAB